Treatment with low-dose interferon-alpha in Bulgarian HBeAg-negative patients with chronic hepatitis B

被引：1
|
作者：
Krastev, Z [1 ]
Antonov, K [1 ]
Vassilev, M [1 ]
Jelev, D [1 ]
机构：
[1] Med Univ Sofia, Gastroenterol Clin, Sofia, Bulgaria
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 1998年 / 27卷 / 04期
关键词：
D O I：
10.1097/00004836-199812000-00021
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：367 / 368
页数：2
相关论文
共 50 条
  • [21] Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients
    Li, Minghui
    Sun, Fangfang
    Bi, Xiaoyue
    Lin, Yanjie
    Yang, Liu
    Lu, Yao
    Zhang, Lu
    Wan, Gang
    Yi, Wei
    Zhao, Linqing
    Xie, Yao
    VIROLOGICA SINICA, 2022, 37 (03) : 390 - 397
  • [22] Treatment optimization of HBeAg-negative chronic viral hepatitis B with thymosin-alpha 1
    Hatzis, G.
    Tsolas, O.
    ARCHIVES OF HELLENIC MEDICINE, 2010, 27 (04): : 594 - 598
  • [23] Consolidation treatment needed for sustained HBsAg-negative response induced by interferon-alpha in HBeAg positive chronic hepatitis B patients
    Minghui Li
    Fangfang Sun
    Xiaoyue Bi
    Yanjie Lin
    Liu Yang
    Yao Lu
    Lu Zhang
    Gang Wan
    Wei Yi
    Linqing Zhao
    Yao Xie
    Virologica Sinica, 2022, (03) : 390 - 397
  • [24] Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues
    Papatheodoridis, George V.
    LIVER INTERNATIONAL, 2011, 31 : 95 - 103
  • [25] Rate and determinants of antiviral treatment initiation for patients with HBeAg-negative chronic hepatitis B
    Mutimer, David
    Elsharkawy, Ahmed
    Hathorn, Emma
    Arunkumar, Selvi
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (08) : 694 - 699
  • [26] In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with HbeAg-negative chronic hepatitis B
    Gramenzi, A
    Cursaro, C
    Margotti, M
    Persico, I
    Scuteri, A
    Loggi, E
    Lorenzini, S
    Bernardi, M
    Andreone, P
    HEPATOLOGY, 2005, 42 (04) : 587A - 588A
  • [27] Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B
    Paolo Del Poggio
    Maurizio Zaccanelli
    Maria Oggionni
    Silvia Colombo
    Carlo Jamoletti
    Vesna Puhalo
    World Journal of Gastroenterology, 2007, (30) : 4096 - 4099
  • [28] Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B
    Del Poggio, Paolo
    Zaccanelli, Maurizio
    Oggionni, Maria
    Colombo, Silvia
    Jamoletti, Carlo
    Puhalo, Vesna
    WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (30) : 4096 - 4099
  • [29] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [30] Efficacy of lamivudine in HBeAg-negative chronic hepatitis B
    Rizzetto, M
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (04) : 435 - 451
12345